"Coordination" of Bristol-Myers' and Squibb's U.S. operations is expected to be completed by July and all international operations by year-end, Chairman and CEO Richard Gelb tells securities analysts April 25. "Most" of the coordination of worldwide manufacturing operations should be finished by the end of 1991, Gelb predicted.
You may also be interested in...
Switzerland’s GeNeuro will study whether its monoclonal antibody temelimab can prevent long-COVID, after data for the first time linked activation of human endogenous retroviruses (HERVs) to the condition and its associated neurological symptoms.
Executives On The Move: CFO Promoted At Novavax, Gilead Gets New Executive Vice President Of Research
Alpha Cognition, F2G and Immune Pharmaceuticals pick up new CEOs, and there is a new chief medical officer at Gemini Therapeutics.
Details of how the FDA plans to conduct remote evaluations of manufacturing facilities during the COVID-19 pandemic have been set out in guidance published by the US agency.